NeuPath Health Inc Cash Flow Conversion Efficiency
NeuPath Health Inc cash flow conversion efficiency. Based on the latest financial reports, NeuPath Health Inc (NPTH) has a cash flow conversion efficiency ratio of 0.039x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$906.00K ≈ $655.39K USD) by net assets (CA$23.43 Million ≈ $16.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of NeuPath Health Inc (2019–2025)
Cash flow conversion efficiency of NeuPath Health Inc from 2019 to 2025. This chart illustrates how NeuPath Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NPTH stock price and chart for real-time trading data and today's change.
NeuPath Health Inc Cash Flow Conversion Ratio Explained
NeuPath Health Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
NeuPath Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NeuPath Health Inc ranked by their cash flow conversion efficiency. Also see NeuPath Health Inc market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The Peria Karamalai Tea & Produce Company Limited
NSE:PKTEA
|
-0.002x |
|
Key Tronic Corporation
NASDAQ:KTCC
|
-0.039x |
|
Obducat AB (publ)
F:OBD
|
0.647x |
|
ISA Holdings Ltd
JSE:ISA
|
0.239x |
|
Tuksu Engineering & ConstructionLtd
KQ:026150
|
-0.084x |
|
RDE, Inc.
NASDAQ:GIFT
|
-0.002x |
|
Avrupa Yatirim Holding AS
IS:AVHOL
|
0.093x |
|
SONOKONG Co. Ltd
KQ:066910
|
0.007x |
Annual Cash Flow Conversion Efficiency for NeuPath Health Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of NeuPath Health Inc from 2019 to 2025. Review NPTH FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$20.95 Million ≈ $15.16 Million |
CA$4.00 Million ≈ $2.90 Million |
0.191x | +57.07% |
| 2024-12-31 | CA$21.43 Million ≈ $15.50 Million |
CA$2.61 Million ≈ $1.89 Million |
0.122x | -12.33% |
| 2023-12-31 | CA$21.84 Million ≈ $15.80 Million |
CA$3.03 Million ≈ $2.19 Million |
0.139x | +307.07% |
| 2022-12-31 | CA$21.65 Million ≈ $15.66 Million |
CA$738.00K ≈ $533.86K |
0.034x | -54.12% |
| 2021-12-31 | CA$25.83 Million ≈ $18.69 Million |
CA$1.92 Million ≈ $1.39 Million |
0.074x | +417.69% |
| 2020-12-31 | CA$27.62 Million ≈ $19.98 Million |
CA$-646.00K ≈ $-467.31K |
-0.023x | +76.83% |
| 2019-12-31 | CA$9.77 Million ≈ $7.07 Million |
CA$-986.00K ≈ $-713.26K |
-0.101x | -- |
About NeuPath Health Inc
NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and di… Read more